Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases
US9265773B2 · kind B2 · utility
0Cited by
26References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 20, 2012 |
| Grant date | Feb 23, 2016 |
| Priority date | — |
| Expiry date | Aug 20, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.